Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

RAYMED LABS vs IPCA LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    RAYMED LABS IPCA LABS RAYMED LABS/
IPCA LABS
 
P/E (TTM) x -7.1 51.7 - View Chart
P/BV x - 5.4 - View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 RAYMED LABS   IPCA LABS
EQUITY SHARE DATA
    RAYMED LABS
Mar-23
IPCA LABS
Mar-23
RAYMED LABS/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs21,062 0.2%   
Low Rs1768 0.2%   
Sales per share (Unadj.) Rs0243.0 0.0%  
Earnings per share (Unadj.) Rs-0.419.4 -2.1%  
Cash flow per share (Unadj.) Rs-0.429.7 -1.3%  
Dividends per share (Unadj.) Rs04.00 0.0%  
Avg Dividend yield %00.4 0.0%  
Book value per share (Unadj.) Rs-5.4230.3 -2.3%  
Shares outstanding (eoy) m4.27253.70 1.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x03.8-  
Avg P/E ratio x-4.447.2 -9.3%  
P/CF ratio (eoy) x-4.630.8 -14.8%  
Price / Book Value ratio x-0.34.0 -8.2%  
Dividend payout %020.6 -0.0%   
Avg Mkt Cap Rs m8232,120 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m012,876 0.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m061,642 0.0%  
Other income Rs m01,518 0.0%   
Total revenues Rs m063,160 0.0%   
Gross profit Rs m-29,033 -0.0%  
Depreciation Rs m02,616 0.0%   
Interest Rs m0482 0.0%   
Profit before tax Rs m-27,453 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m02,534 0.0%   
Profit after tax Rs m-24,919 -0.0%  
Gross profit margin %014.7- 
Effective tax rate %034.0 -0.0%   
Net profit margin %08.0- 
BALANCE SHEET DATA
Current assets Rs m051,893 0.0%   
Current liabilities Rs m118,058 0.0%   
Net working cap to sales %054.9- 
Current ratio x0.12.9 1.9%  
Inventory Days Days051- 
Debtors Days Days06- 
Net fixed assets Rs m234,336 0.0%   
Share capital Rs m43254 16.8%   
"Free" reserves Rs m-6658,167 -0.1%   
Net worth Rs m-2358,420 -0.0%   
Long term debt Rs m06,518 0.0%   
Total assets Rs m286,229 0.0%  
Interest coverage x016.5-  
Debt to equity ratio x00.1 -0.0%  
Sales to assets ratio x00.7 0.0%   
Return on assets %-109.56.3 -1,747.8%  
Return on equity %7.48.4 88.0%  
Return on capital %7.412.2 60.6%  
Exports to sales %042.9-  
Imports to sales %013.3-  
Exports (fob) Rs mNA26,434 0.0%   
Imports (cif) Rs mNA8,178 0.0%   
Fx inflow Rs m026,434 0.0%   
Fx outflow Rs m08,178 0.0%   
Net fx Rs m018,257 0.0%   
CASH FLOW
From Operations Rs m-28,058 -0.0%  
From Investments Rs m2-7,250 -0.0%  
From Financial Activity Rs mNA5,072 0.0%  
Net Cashflow Rs m05,881 -0.0%  

Share Holding

Indian Promoters % 28.4 46.3 61.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.0 44.8 2.1%  
FIIs % 0.0 10.3 -  
ADR/GDR % 0.0 0.0 -  
Free float % 71.6 53.7 133.4%  
Shareholders   1,498 82,809 1.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare RAYMED LABS With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on RAYMED LABS. vs IPCA Labs

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

RAYMED LABS. vs IPCA Labs Share Price Performance

Period RAYMED LABS. IPCA Labs S&P BSE HEALTHCARE
1-Day 0.00% 3.35% 1.18%
1-Month 3.32% 4.27% -0.75%
1-Year 6.86% 56.49% 61.82%
3-Year CAGR 31.90% 9.46% 18.16%
5-Year CAGR -1.90% 20.88% 19.79%

* Compound Annual Growth Rate

Here are more details on the RAYMED LABS. share price and the IPCA Labs share price.

Moving on to shareholding structures...

The promoters of RAYMED LABS. hold a 28.4% stake in the company. In case of IPCA Labs the stake stands at 46.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of RAYMED LABS. and the shareholding pattern of IPCA Labs.

Finally, a word on dividends...

In the most recent financial year, RAYMED LABS. paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

IPCA Labs paid Rs 4.0, and its dividend payout ratio stood at 20.6%.

You may visit here to review the dividend history of RAYMED LABS., and the dividend history of IPCA Labs.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.